Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 0.3% | 12.0% | 18.1% | 14.3% | 15.0% | 22.5% | 17.7% | 17.9% | 20.8% | 25.8% | 43.3% | 21.1% | 22.2% | 20.8% | 23.5% | 28.7% | 18.9% | 28.9% | 26.1% | 22.4% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 48.6%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Equity (ROE) for Edwards Lifesciences Corporation have been 25.4% over the past three years, and 25.7% over the past five years.
As of today, Edwards Lifesciences Corporation's Return on Equity (ROE) is 48.6%, which is higher than industry median of (22.6%). It indicates that Edwards Lifesciences Corporation's Return on Equity (ROE) is Good.